These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21464170)

  • 1. Is this pill safe? Substandard medicines, mistaken solutions.
    Fried M
    CMAJ; 2011 May; 183(8):984. PubMed ID: 21464170
    [No Abstract]   [Full Text] [Related]  

  • 2. Fraudulent and substandard medicines: getting away with murder?
    Edwards IR
    Drug Saf; 2011 Jun; 34(6):445-8. PubMed ID: 21585218
    [No Abstract]   [Full Text] [Related]  

  • 3. The primacy of public health considerations in defining poor quality medicines.
    Newton PN; Amin AA; Bird C; Passmore P; Dukes G; Tomson G; Simons B; Bate R; Guerin PJ; White NJ
    PLoS Med; 2011 Dec; 8(12):e1001139. PubMed ID: 22162953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
    't Hoen E; Pascual F
    J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
    Tadeg H; Berhane Y
    East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law.
    Olliaro E; Olliaro P; Ho CWL; Ravinetto R
    Am J Trop Med Hyg; 2020 Feb; 102(2):262-267. PubMed ID: 31746313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edible unclonable functions.
    Leem JW; Kim MS; Choi SH; Kim SR; Kim SW; Song YM; Young RJ; Kim YL
    Nat Commun; 2020 Jan; 11(1):328. PubMed ID: 31949156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substandard/counterfeit antimicrobial drugs.
    Kelesidis T; Falagas ME
    Clin Microbiol Rev; 2015 Apr; 28(2):443-64. PubMed ID: 25788516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global scenario of counterfeit antimalarials: A potential threat.
    Arora T; Sharma S
    J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stemming the global trade in falsified and substandard medicines.
    Gostin LO; Buckley GJ; Kelley PW
    JAMA; 2013 Apr; 309(16):1693-4. PubMed ID: 23579391
    [No Abstract]   [Full Text] [Related]  

  • 11. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications.
    Schwartzman GH; Dekker PK; Silverstein AS; Fontecilla NM; Norton SA
    Dermatol Clin; 2022 Apr; 40(2):227-236. PubMed ID: 35366975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Medicines Quality Database: a free public resource.
    Krech LA; El-Hadri L; Evans L; Fouche T; Hajjou M; Lukulay P; Phanouvong S; Pribluda V; Roth L
    Bull World Health Organ; 2014 Jan; 92(1):2-2A. PubMed ID: 24391291
    [No Abstract]   [Full Text] [Related]  

  • 14. Counterfeit drugs: an Australian perspective.
    Hensey CC; Gwee A
    Med J Aust; 2016 May; 204(9):344. PubMed ID: 27169964
    [No Abstract]   [Full Text] [Related]  

  • 15. Forensic pharmacovigilance and substandard or counterfeit drugs.
    Labadie J
    Int J Risk Saf Med; 2012; 24(1):37-9. PubMed ID: 22436258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].
    Baxerres C
    Bull Soc Pathol Exot; 2014 May; 107(2):121-6. PubMed ID: 24639135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The silent epidemic of substandard and falsified medicines in low- and middle-income countries: heed lessons from the tragic deaths of children in Indonesia.
    MohanaSundaram A; Padhi BK; Mohanty A; Shrestha S; Sah R
    Int J Surg; 2023 Mar; 109(3):523-525. PubMed ID: 36906790
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
    Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.